Proteome analysis of hepatic non-parenchymal cells of immune liver fibrosis rats

Science China Life Sciences

Volumn 57, Issue 3, 2014, Pages 303-314

  Zhao, QianQian ^a   Feng, YanLing ^a   Jia, XiaoFang ^a   Yin, Lin ^a   Zheng, Ye ^a   Ouyang, DongSheng ^b   Zhou, HongHao ^b   Zhang, LiJun ^a,b  

^a FUDAN UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

liver fibrosis; non parenchymal cells; protein disulfide isomerase associated protein 3; proteomics

Indexed keywords

RATTUS; SUIDAE;

PROTEIN DISULFIDE ISOMERASE; PROTEOME;

AMINO ACID SEQUENCE; ANIMAL; DISEASE MODEL; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; MALE; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PROCEDURES; PROTEOMICS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; MALE; MOLECULAR SEQUENCE DATA; PROTEIN DISULFIDE-ISOMERASES; PROTEOME; PROTEOMICS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84895924451     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-014-4619-0     Document Type: Article

References (34)

1. Yuen MF, Hou JL, Chutaputti A. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol, 2009, 24: 346-353.
2. Shen LP, Zhang Y, Wang F, Zhang S, Yang JY, Fang KX, Yu T, Wang XY, Zhang WY, Bi SL. Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme. Epidemiol Infect, 139: 1159-1165.
3. Knolle PA, Gerken G. Local control of the immune response in the liver. Immunol Rev, 2000, 174: 21-34.
4. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J Immunol, 2002, 169: 5188-5195.
5. Ramadori G, Moriconi F, Malik I, Dudas J. Physiology and pathophysiology of liver inflammation, damage and repair. J Physiol Pharmacol, 2008, 59(Suppl 1): 107-117.
6. Wu J, Meng Z, Jiang M, Pei R, Trippler M, Broering R, Bucchi A, Sowa JP, Dittmer U, Yang D, Roggendorf M, Gerken G, Lu M, Schlaak JF. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology, 2009, 49: 1132-1140.
7. Baba Y, Uetsuka K, Nakayama H, Dot K. Rat strain differences in the early stage of porcine-serum-induced hepatic fibrosis. Exp Toxicol Pathol, 2004, 55: 325-330.
8. Tsukamoto H, Matsuoka M, French SW. Experimental models of hepatic fibrosis: a review. Semin Liver Dis, 1990, 10: 56-65.
9. Schuppan D, Ruehl M, Somasundaram R, Hahn EG. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis, 2001, 21: 351-372.
10. Fujisawa G, Muto S, Okada K, Kusano E, Ishibashi S. Mineralocorticoid receptor antagonist spironolactone prevents pig serum-induced hepatic fibrosis in rats. Transl Res, 2006, 148: 149-156.
11. Villeneuve JP. The natural history of chronic hepatitis B virus infection. J Clin Virol, 2005, 34(Suppl 1): S139-142.
12. Smyth R, Lane CS, Ashiq R, Turton JA, Clarke CJ, Dare TO, York MJ, Griffiths W, Munday MR. Proteomic investigation of urinary markers of carbon-tetrachloride-induced hepatic fibrosis in the Hanover Wistar rat. Cell Biol Toxicol, 2009, 25: 499-512.
13. Spano D, Cimmino F, Capasso M, D'Angelo F, Zambrano N, Terracciano L, Iolascon A. Changes of the hepatic proteome in hepatitis B-infected mouse model at early stages of fibrosis. J Proteome Res, 2008, 7: 2642-2653.
14. Liu Y, He J, Ji S, Wang Q, Pu H, Jiang T, Meng L, Yang X, Ji J. Comparative studies of early liver dysfunction in senescence-accelerated mouse using mitochondrial proteomics approaches. Mol Cell Proteomics, 2008, 7: 1737-1747.
15. Diamond DL, Jacobs JM, Paeper B, Proll SC, Gritsenko MA, Carithers RL Jr, Larson AM, Yeh MM, Camp DG 2nd, Smith RD, Katze MG. Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction. Hepatology, 2007, 46: 649-657.
16. Mölleken C, Sitek B, Henkel C, Poschmann G, Sipos B, Wiese S, Warscheid B, Broelsch C, Reiser M, Friedman SL, Torné I, Schlosser A, Klöppel G, Schmiegel W, Meyer HE, Holmskov U, Stühler K. Detection of novel biomarkers of liver cirrhosis by proteomic analysis. Hepatology, 2009, 49: 1257-1266.
17. Teufelhofer O, Parzefall W, Elbling L, Kainzbauer E, Grasl-Kraupp B, Zielinski C, Schulte-Hermann R, Gerner C. Divide and conquer: rat liver tissue proteomics based on the analysis of purified constituents. Electrophoresis, 2006, 27: 4112-4120.
18. Hirsch J, Hansen KC, Choi S, Noh J, Hirose R, Roberts JP, Matthay MA, Burlingame AL, Maher JJ, Niemann CU. Warm ischemia-induced alterations in oxidative and inflammatory proteins in hepatic Kupffer cells in rats. Mol Cell Proteomics, 2006, 5: 979-986.
19. Li X, Xie C, Cao J, He Q, Cao R, Lin Y, Jin Q, Chen P, Wang X, Liang S. An in vivo membrane density perturbation strategy for identification of liver sinusoidal surface proteome accessible from the vasculature. J Proteome Res, 2009, 8: 123-132.
20. Kristensen DB, Kawada N, Imamura K, Miyamoto Y, Tateno C, Seki S, Kuroki T, Yoshizato K. Proteome analysis of rat hepatic stellate cells. Hepatology, 2000, 32: 268-277.
21. Zhang L, Peng X, Zhang Z, Feng Y, Jia X, Shi Y, Yang H, Zhang Z, Zhang X, Liu L, Yin L, Yuan Z. Subcellular proteome analysis unraveled annexin A2 related to immune liver fibrosis. J Cell Biochem, 2010, 110: 219-228.
22. Parzefall W, Kainzbauer E, Qin HM, Chabicovsky M, Schulte-Hermann R. Response of isolated hepatocytes from carcinogen sensitive (C3H) and insensitive (C57BL) mice to signals inducing replication or apoptosis. Arch Toxicol, 2002, 76: 699-706.
23. Friedman SL, Roll FJ. Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Anal Biochem, 1987, 161: 207-218.
24. Wu J, Ma H, Qu Q, Zhou WJ, Luo YP, Thangaraj H, Lowrie DB, Fan XY. Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice. Vaccine, 2011, 29: 7624-7630.
25. Zhang LJ, Wang XE, Peng X, Wei YJ, Cao R, Liu Z, Xiong JX, Yin XF, Ping C, Liang S. Proteomic analysis of low-abundant integral plasma membrane proteins based on gels. Cell Mol Life Sci, 2006, 63: 1790-1804.
26. Zhang L, Jia X, Zhang X, Sun J, Peng X, Qi T, Ma F, Yin L, Yao Y, Qiu C, Lu H. Proteomic analysis of PBMCs: characterization of potential HIV-associated proteins. Proteome Sci, 2010, 8: 12.
27. Scoazec JY, Feldmann G. In situ immunophenotyping study of endothelial cells of the human hepatic sinusoid: results and functional implications. Hepatology, 1991, 14: 789-797.
28. Couvelard A, Scoazec JY, Feldmann G. Expression of cell-cell and cell-matrix adhesion proteins by sinusoidal endothelial cells in the normal and cirrhotic human liver. Am J Pathol, 1993, 143: 738-752.
29. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, Mann M. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics, 2005, 4: 1265-1272.
30. Shinoda K, Tomita M, Ishihama Y. emPAI Calc-for the estimation of protein abundance from large-scale identification data by liquid chromatography-tandem mass spectrometry. Bioinformatics, 2010, 26: 576-577.
31. Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury. Gastroenterology, 2008, 134: 1641-1654.
32. Aroor AR, Roy LJ, Restrepo RJ, Mooney BP, Shukla SD. A proteomic analysis of liver after ethanol binge in chronically ethanol treated rats. Proteome Sci, 2012, 10: 29.
33. Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology, 2006, 43: S31-44.
34. Serviddio G, Bellanti F, Sastre J, Vendemiale G, Altomare E. Targeting mitochondria: a new promising approach for the treatment of liver diseases. Curr Med Chem, 2010, 17: 2325-2337.